Cargando…

RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m(6)A-YTHDF2-dependent manner

RNA N6-methyladenosine (m(6)A) is an emerging regulator of mRNA modifications and represents a novel player in tumorigenesis. Although it has functional significance in both pathological and physiological processes, the role of m(6)A modification in pancreatic ductal cancer (PDAC) remains elusive. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Zhen, Shi, Si, Xu, Jin, Liu, Xiaomeng, Lei, Yubin, Zhang, Bo, Hua, Jie, Meng, Qingcai, Wang, Wei, Yu, Xianjun, Liang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106577/ https://www.ncbi.nlm.nih.gov/pubmed/35422475 http://dx.doi.org/10.1038/s41388-022-02306-w

Ejemplares similares

Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
por: Zheng, Qing-Kang, et al.
Publicado: (2021)

N(6)-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury
por: Xu, Kaiwei, et al.
Publicado: (2020)

Nitric oxide inhibits FTO demethylase activity to regulate N(6)-methyladenosine mRNA methylation
por: Kuschman, Hannah Petraitis, et al.
Publicado: (2023)

N(6) ‐methyladenosine RNA demethylase FTO regulates extracellular matrix‐related genes and promotes pancreatic cancer cell migration and invasion
por: Wang, Wei, et al.
Publicado: (2022)

N(6)-Methyladenosine: a conformational marker that regulates the substrate specificity of human demethylases FTO and ALKBH5
por: Zou, Shui, et al.
Publicado: (2016)

RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
por: Niu, Yi, et al.
Publicado: (2019)

FTO-dependent m(6)A regulates muscle fiber remodeling in an NFATC1–YTHDF2 dependent manner
por: Wang, Wengang, et al.
Publicado: (2023)

The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers
por: Wang, Jin-yan, et al.
Publicado: (2020)

N(6)‐Methyladenosine Demethylase FTO Contributes to Neuropathic Pain by Stabilizing G9a Expression in Primary Sensory Neurons
por: Li, Yize, et al.
Publicado: (2020)

N6-methyladenosine demethylase FTO targets pre-mRNAs and regulates alternative splicing and 3′-end processing
por: Bartosovic, Marek, et al.
Publicado: (2017)

A fluorescent methylation-switchable probe for highly sensitive analysis of FTO N(6)-methyladenosine demethylase activity in cells
por: Cheong, Adeline, et al.
Publicado: (2018)

N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability
por: Zou, Libin, et al.
Publicado: (2022)

FTO promotes innate immunity by controlling NOD1 expression via m(6)A-YTHDF2 manner in teleost
por: Geng, Shang, et al.
Publicado: (2022)

A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO
por: Toh, Joel D. W., et al.
Publicado: (2015)

N6‐methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO‐PGC‐1α signalling axis
por: Zhuang, Changshui, et al.
Publicado: (2019)

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner
por: Guo, Xingya, et al.
Publicado: (2020)

N(6)-Methyladenosine RNA Demethylase FTO Promotes Gastric Cancer Metastasis by Down-Regulating the m6A Methylation of ITGB1
por: Wang, Duo, et al.
Publicado: (2021)

A novel inhibitor of N(6)-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities
por: Xie, Guoyou, et al.
Publicado: (2022)

O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner
por: Yang, Yang, et al.
Publicado: (2023)

Fat mass and obesity-associated factor (FTO)-mediated N6-methyladenosine regulates spermatogenesis in an age-dependent manner
por: Wu, Yifei, et al.
Publicado: (2023)

Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner
por: WANG, Zhenyu, et al.
Publicado: (2022)

FTO Regulated Intramuscular Fat by Targeting APMAP Gene via an m(6)A-YTHDF2-dependent Manner in Rex Rabbits
por: Luo, Gang, et al.
Publicado: (2023)

RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation
por: Wang, Jing, et al.
Publicado: (2021)

The RNA N6-Methyladenosine Demethylase FTO Promotes Head and Neck Squamous Cell Carcinoma Proliferation and Migration by Increasing CTNNB1
por: Zhang, Yu, et al.
Publicado: (2021)

N6-methyladenosine demethylase FTO impairs hepatic ischemia–reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation
por: Du, Ying Dong, et al.
Publicado: (2021)

N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
por: Chen, Lin, et al.
Publicado: (2023)

N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m(6)A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics
por: Zhou, You, et al.
Publicado: (2022)

m6A demethylase FTO and osteoporosis: potential therapeutic interventions
por: Huang, Mei, et al.
Publicado: (2023)

m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
por: Zeng, Juan, et al.
Publicado: (2021)

Profiling of N6-methyladenosine methylation in porcine longissimus dorsi muscle and unravelling the hub gene ADIPOQ promotes adipogenesis in an m(6)A-YTHDF1–dependent manner
por: Gong, Huanfa, et al.
Publicado: (2023)

RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner
por: Shen, Dingcheng, et al.
Publicado: (2023)

N(6)‐methyladenosine‐binding protein YTHDF1 suppresses EBV replication and promotes EBV RNA decay
por: Xia, Tian‐Liang, et al.
Publicado: (2021)

FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner
por: Huang, Jiapeng, et al.
Publicado: (2022)

Small-Molecule Ebselen Binds to YTHDF Proteins Interfering with the Recognition of N(6)-Methyladenosine-Modified RNAs
por: Micaelli, Mariachiara, et al.
Publicado: (2022)

The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome.
por: Tsukuda, Senko, et al.
Publicado: (2023)

The N(6)-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response
por: Zong, Xin, et al.
Publicado: (2021)

Retraction Notice to: m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
por: Zeng, Juan, et al.
Publicado: (2022)

FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms
por: Azzam, Sarah Kassem, et al.
Publicado: (2022)

N(6)-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO
por: Jia, Guifang, et al.
Publicado: (2011)

Substrates of the m(6)A demethylase FTO: FTO-LINE1 RNA axis regulates chromatin state in mESCs
por: Sommerkamp, Pia
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iv2g87psv0osbemj550u75r898